Supplementary Materials

The PDF file includes:

  • Fig. S1. Characterization of Msut2 KO mice.
  • Fig. S2. Msut2 KO decreases accumulation of pathological tau.
  • Fig. S3. Msut2 KO mice have normal cognitive and locomotor abilities.
  • Fig. S4. MSUT2, PABPN1, and poly(A) mRNA colocalize in nuclear speckles.
  • Fig. S5. MSUT2 and PABPN1 have opposing effects on tau aggregation.
  • Fig. S6. MSUT2 overexpression in mouse hippocampus using AAV-Msut2.
  • Fig. S7. Effect of MSUT2 overexpression on astrocytes in the mouse hippocampus.
  • Fig. S8. Msut2 deletion suppresses reactive microgliosis in PS19 mice.
  • Fig. S9. Msut2 deletion does not protect against astrocytosis induced by kainic acid.
  • Fig. S10. Schematic showing the potential molecular mechanism of MSUT2 activity.
  • Legends for tables S1 to S4

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Table S1 (Microsoft Excel format). Msut2 KO versus C57BL/6 RNA-seq gene expression changes.
  • Table S2 (Microsoft Excel format). Msut2 KO versus C57BL/6 RNA-seq exon inclusion changes.
  • Table S3 (Microsoft Excel format). Msut2 KO versus C57BL/6 RNA-seq poly(A) site selection.
  • Table S4 (Microsoft Excel format). Characteristics of human AD cases.
  • Data file S1 (Microsoft Excel format). Source data for Figs. 1D, 4, A to D, and 5, D to I.